High-dose aciclovir in CMV infection prophylaxis after allogeneic HSCT: a single-center long-term experience

There is only limited data on cytomegalovirus (CMV) prophylaxis with high-dose (HD) aciclovir after allogeneic hematopoietic stem cell transplantation (allo-HSCT). We performed a retrospective analysis on a total of 179 patients who underwent their allo-HSCT with HD-aciclovir prophylaxis at our cent...

Descripción completa

Detalles Bibliográficos
Autores principales: Kabut, Tomáš, Weinbergerová, Barbora, Folber, František, Lengerová, Martina, Mayer, Jiří
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10622319/
https://www.ncbi.nlm.nih.gov/pubmed/37612466
http://dx.doi.org/10.1038/s41409-023-02081-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10622319/
https://www.ncbi.nlm.nih.gov/pubmed/37612466
http://dx.doi.org/10.1038/s41409-023-02081-6

Ejemplares similares